Literature for CA074 (C01.060 inhibitor)
(Topics flags: S Structure, T Target, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)
-
Jiang,M., Meng,J., Zeng,F., Qing,H., Hook,G., Hook,V., Wu,Z. and Ni,J.
Cathepsin B inhibition blocks neurite outgrowth in cultured neurons by regulating lysosomal trafficking and remodeling
J Neurochem (2020) PubMed Europe PubMed DOI I -
Coleman,M.D., Ha,S.D., Haeryfar,S.M.M., Barr,S.D. and Kim,S.O.
Cathepsin B plays a key role in optimal production of the influenza A virus
J Virol Antivir Res (2018) 2018, 1-20. PubMed Europe PubMed DOI PMC EPMC I -
Dietze,R., Starzinski-Powitz,A., Scheiner-Bobis,G., Tinneberg,H.R., Meinhold-Heerlein,I. and Konrad,L.
Lysophosphatidic acid triggers cathepsin B-mediated invasiveness of human endometriotic cells
Biochim Biophys Acta Mol Cell Biol Lipids (2018) 1863, 1369-1377. PubMed Europe PubMed DOI I -
Gonzalez,E.A., Martins,G.R., Tavares,A.M.V., Viegas,M., Poletto,E., Giugliani,R., Matte,U. and Baldo,G.
Cathepsin B inhibition attenuates cardiovascular pathology in mucopolysaccharidosis I mice
Life Sci (2018) 196, 102-109. PubMed Europe PubMed DOI I -
Llorente,P., Kristen,H., Sastre,I., Toledano-Zaragoza,A., Aldudo,J., Recuero,M. and Bullido,M.J.
A free radical-generating system regulates amyloid oligomers: involvement of cathepsin B
J Alzheimers Dis (2018) 66, 1397-1408. PubMed Europe PubMed DOI I -
Tang,Y., Cao,G., Min,X., Wang,T., Sun,S., Du,X. and Zhang,W.
Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation
J Physiol Biochem (2018) 74, 503-510. PubMed Europe PubMed DOI I -
Shoji,A., Suenaga,Y., Hosaka,A., Ishida,Y., Yanagida,A. and Sugawara,M.
Inhibitory assay for degradation of collagen IV by cathepsin B with a surface plasmon resonance sensor
J Pharm Biomed Anal (2017) 145, 79-83. PubMed Europe PubMed DOI I -
Wu,Z., Ni,J., Liu,Y., Teeling,J.L., Takayama,F., Collcutt,A., Ibbett,P. and Nakanishi,H.
Cathepsin B plays a critical role in inducing Alzheimer's disease-like phenotypes following chronic systemic exposure to lipopolysaccharide from Porphyromonas gingivalis in mice
Brain Behav Immun (2017) 65, 350-361. PubMed Europe PubMed DOI I -
Xu,Y., Wang,J., Song,X., Wei,R., He,F., Peng,G. and Luo,B.
Protective mechanisms of CA074-me (other than cathepsin-B inhibition) against programmed necrosis induced by global cerebral ischemia/reperfusion injury in rats
Brain Res Bull (2016) 120, 97-105. PubMed Europe PubMed DOI I -
Zuo,X., Hou,Q., Jin,J., Zhan,L., Li,X., Sun,W., Lin,K. and Xu,E.
Inhibition of cathepsin B alleviates secondary degeneration in ipsilateral thalamus after focal cerebral infarction in adult rats
J Neuropathol Exp Neurol (2016) 75, 816-826. PubMed Europe PubMed DOI I -
Mashamba-Thompson,T. and Soliman,M.E.S.
Insight into the binding theme of CA-074Me to cathepsin B: molecular dynamics simulations and scaffold hopping to identify potential analogues as anti-neurodegenerative diseases
Med Chem Res (2015) 24, 701-713. DOI I -
Patel,N., Nizami,S., Song,L., Mikami,M., Hsu,A., Hickernell,T., Chandhanayingyong,C., Rho,S., Compton,J.T., Caldwell,J.M., Kaiser,P.B., Bai,H., Lee,H.G., Fischer,C.R. and Lee,F.Y.
CA-074Me compound inhibits osteoclastogenesis via suppression of the NFATc1 and c-Fos signaling pathways
J Orthop Res (2015) 33, 1474-1486. PubMed Europe PubMed DOI I -
Zhang,L., Fu,X.H., Yu,Y., Shui,R.H., Li,C., Zeng,H.Y., Qiao,Y.L., Ni,L.Y. and Wang,Q.
Treatment with CA-074Me, a cathepsin B inhibitor, reduces lung interstitial inflammation and fibrosis in a rat model of polymyositis
Lab Invest (2015) 95, 65-77. PubMed Europe PubMed DOI I -
Cho,K., Yoon,S.Y., Choi,J.E., Kang,H.J., Jang,H.Y. and Kim,D.H.
CA-074Me, a cathepsin B inhibitor, decreases APP accumulation and protects primary rat cortical neurons treated with okadaic acid
Neurosci Lett (2013) 548, 222-227. PubMed Europe PubMed DOI I -
Feng,Y., Ni,L. and Wang,Q.
Administration of cathepsin B inhibitor CA-074Me reduces inflammation and apoptosis in polymyositis
J Dermatol Sci (2013) 72, 158-167. PubMed Europe PubMed DOI I -
Liu,A., Gao,X., Zhang,Q. and Cui,L.
Cathepsin B inhibition attenuates cardiac dysfunction and remodeling following myocardial infarction by inhibiting the NLRP3 pathway
Mol Med Rep (2013) 8, 361-366. PubMed Europe PubMed DOI T I -
Yan,B.Z., Chen,L.Y., Kang,L., Wang,X.R., Bi,M.R., Wang,W. and Yang,B.S.
Hepatoprotective effects of cathepsin B inhibitor on acute hepatic failure induced by lipopolysaccharide/D-galactosamine in mice
Hepatobiliary Pancreat Dis Int (2013) 12, 80-86. PubMed Europe PubMed DOI I -
Ha,S.D., Park,S., Hattlmann,C.J., Barr,S.D. and Kim,S.O.
Inhibition or deficiency of cathepsin B leads defects in HIV-1 Gag pseudoparticle release in macrophages and HEK293T cells
Antiviral Res (2012) 93, 175-184. PubMed Europe PubMed DOI I -
Ni,H., Yan,J.Z., Zhang,L.L., Feng,X. and Wu,X.R.
Long-term effects of recurrent neonatal seizures on neurobehavioral function and related gene expression and its intervention by inhibitor of cathepsin B
Neurochem Res (2012) 37, 31-39. PubMed Europe PubMed DOI I -
Withana,N.P., Blum,G., Sameni,M., Slaney,C., Anbalagan,A., Olive,M.B., Bidwell,B.N., Edgington,L., Wang,L., Moin,K., Sloane,B.F., Anderson,R.L., Bogyo,M.S. and Parker,B.S.
Cathepsin B inhibition limits bone metastasis in breast cancer
Cancer Res (2012) 72, 1199-1209. PubMed Europe PubMed DOI I -
Jilkova,A., Rezacova,P., Lepsik,M., Horn,M., Vachova,J., Fanfrlik,J., Brynda,J., McKerrow,J.H., Caffrey,C.R. and Mares,M.
Structural basis for inhibition of cathepsin B drug target from the human blood fluke, Schistosoma mansoni
J Biol Chem (2011) 286, 35770-35781. PubMed Europe PubMed DOI S I -
Steverding,D.
The cathepsin B-selective inhibitors CA-074 and CA-074Me inactivate cathepsin L under reducing conditions
Open Enzyme Inhib J (2011) 4, 11-16. DOI I -
Victor,B.C., Anbalagan,A., Mostafa Mohamed,M., Sloane,B.F. and Cavallo-Medved,D.
Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion
Breast Cancer Res (2011) 13, R115-R115. PubMed Europe PubMed DOI I -
Bien,S., Rimmbach,C., Neumann,H., Niessen,J., Reimer,E., Ritter,C.A., Rosskopf,D., Cinatl,J., Michaelis,M., Schroeder,H.W. and Kroemer,H.K.
Doxorubicin-induced cell death requires cathepsin B in HeLa cells
Biochem Pharmacol (2010) 80, 1466-1477. PubMed Europe PubMed DOI I -
Eykelbosh,A.J. and Van Der Kraak,G.
A role for the lysosomal protease cathepsin B in zebrafish follicular apoptosis
Comp Biochem Physiol A Mol Integr Physiol (2010) 156, 218-223. PubMed Europe PubMed DOI I -
Luo,C.L., Chen,X.P., Yang,R., Sun,Y.X., Li,Q.Q., Bao,H.J., Cao,Q.Q., Ni,H., Qin,Z.H. and Tao,L.Y.
Cathepsin B contributes to traumatic brain injury-induced cell death through a mitochondria-mediated apoptotic pathway
J Neurosci Res (2010) 88, 2847-2858. PubMed Europe PubMed DOI I -
Matarrese,P., Ascione,B., Ciarlo,L., Vona,R., Leonetti,C., Scarsella,M., Mileo,A.M., Catricala',C., Paggi,M.G. and Malorni,W.
Cathepsin B inhibition interferes with metastatic potential of human melanoma: an in vitro and in vivo study
Mol Cancer (2010) 9, 207-207. PubMed Europe PubMed DOI I -
Yan,B.Z., Wang,W., Chen,L.Y., Bi,M.R., Lu,Y.J., Li,B.X. and Yang,B.S.
Role of cathepsin B-mediated apoptosis in fulminant hepatic failure in mice
World J Gastroenterol (2009) 15, 1231-1236. PubMed Europe PubMed DOI PMC EPMC I -
Yoshii,H., Kamiyama,H., Minematsu,K., Goto,K., Mizota,T., Oishi,K., Katunuma,N., Yamamoto,N. and Kubo,Y.
Cathepsin L is required for ecotropic murine leukemia virus infection in NIH3T3 cells
Virology (2009) 394, 227-234. PubMed Europe PubMed DOI I -
Zhang,C., Sun,J.B., Liu,D.C., Cui,Y.Q., Liu,S. and Sun,H.C.
Preliminary research on the pathological role of cathepsin-B in subcutaneous heteroplastic pancreatic carcinoma in nude mice
Chin Med J (Engl) (2009) 122, 2489-2496. PubMed Europe PubMed I -
Hook,V.Y., Kindy,M. and Hook,G.
Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein
J Biol Chem (2008) 283, 7745-7753. PubMed Europe PubMed DOI I -
Zhou,G.H., Yu,W.Z. and Li,X.X.
[The experimental study of specific inhibitor-CA-074Me of cathepsin B suppressing retinal neovascularization]
Zhonghua Yan Ke Za Zhi (2008) 44, 207-211. PubMed Europe PubMed I -
Fujisawa,A., Kambe,N., Saito,M., Nishikomori,R., Tanizaki,H., Kanazawa,N., Adachi,S., Heike,T., Sagara,J., Suda,T., Nakahata,T. and Miyachi,Y.
Disease-associated mutations in CIAS1 induce cathepsin B-dependent rapid cell death of human THP-1 monocytic cells
Blood (2007) 109, 2903-2911. PubMed Europe PubMed DOI I -
Gantt,K.R., Schultz-Cherry,S., Rodriguez,N., Jeronimo,S.M., Nascimento,E.T., Goldman,T.L., Recker,T.J., Miller,M.A. and Wilson,M.E.
Activation of TGF-beta by Leishmania chagasi: importance for parasite survival in macrophages
J Immunol (2003) 170, 2613-2620. PubMed Europe PubMed I -
Jane,D.T., Morvay,L.C., Allen,F., Sloane,B.F. and Dufresne,M.J.
Selective inhibition of cathepsin B with cell-permeable CA074Me negatively affects L6 rat myoblast differentiation
Biochem Cell Biol (2002) 80, 457-465. PubMed Europe PubMed I -
Montaser,M., Lalmanach,G. and Mach,L.
CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells
Biol Chem (2002) 383, 1305-1308. PubMed Europe PubMed DOI I -
[YEAR:11-12-2002]Powers,J.C., Asgian,J.L., Ekici,O.D. and James,K.E.
Irreversible inhibitors of serine, cysteine, and threonine proteases
Chem Rev (11-12-2002) 102, 4639-4750. PubMed Europe PubMed DOI I -
[YEAR:6-3-2001]Therrien,C., Lachance,P., Sulea,T., Purisima,E.O., Qi,H., Ziomek,E., Alvarez-Hernandez,A., Roush,W.R. and Menard,R.
Cathepsins X and B can be differentiated through their respective mono- and dipeptidyl carboxypeptidase activities
Biochemistry (6-3-2001) 40, 2702-2711. PubMed Europe PubMed DOI I -
Bogyo,M., Verhelst,S., Bellingard-Dubouchaud,V., Toba,S. and Greenbaum,D.
Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs
Chem Biol (2000) 7, 27-38. PubMed Europe PubMed DOI I -
Klemencic,I., Carmona,A.K., Cezari,M.H.S., Juliano,M.A., Juliano,L., Guncar,G., Turk,D., Krizaj,I., Turk,V. and Turk,B.
Biochemical characterization of human cathepsin X revealed that the enzyme is an exopeptidase, acting as carboxymonopeptidase or carboxydipeptidase
Eur J Biochem (2000) 267, 5404-5412. PubMed Europe PubMed DOI I -
Yamamoto,A., Tomoo,K., Miyagawa,H., Takaoka,Y., Sumiya,S., Kitamura,K. and Ishida,T.
Molecular dynamics simulations of bovine cathepsin B and its complex with CA074
Chem Pharm Bull (Tokyo) (2000) 48, 480-485. PubMed Europe PubMed I -
Yamamoto,A., Tomoo,K., Hara,T., Murata,M., Kitamura,K. and Ishida,T.
Substrate specificity of bovine cathepsin B and its inhibition by CA074, based on crystal structure refinement of the complex
J Biochem (2000) 127, 635-643. PubMed Europe PubMed S I -
Zhang,T., Maekawa,Y., Hanba,J., Dainichi,T., Nashed,B.F., Hisaeda,H., Sakai,T., Asao,T., Himeno,K., Good,R.A. and Katunuma,N.
Lysosomal cathepsin B plays an important role in antigen processing, while cathepsin D is involved in degradation of the invariant chain inovalbumin-immunized mice
Immunology (2000) 100, 13-20. PubMed Europe PubMed DOI PMC EPMC I -
Peppard,J.V. and Knap,A.K.
Effect of the selective and non-selective cysteine protease inhibitors on the intracellular processing of interleukin 6 by HepG2 cells
In Vitro Cell Dev Biol Anim (1999) 35, 459-464. PubMed Europe PubMed I -
[YEAR:3-3-1998]Matsumoto,K., Murata,M., Sumiya,S., Mizoue,K., Kitamura,K. and Ishida,T.
X-ray crystal structure of papain complexed with cathepsin B-specific covalent-type inhibitor: substrate specificity and inhibitory activity
Biochim Biophys Acta (3-3-1998) 1383, 93-100. PubMed Europe PubMed DOI S I -
Yamashima,T., Kohda,Y., Tsuchiya,K., Ueno,T., Yamashita,J., Yoshioka,T. and Kominami,E.
Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on 'calpain-cathepsin hypothesis'
Eur J Neurosci (1998) 10, 1723-1733. PubMed Europe PubMed I -
Yamamoto,A., Hara,T., Tomoo,K., Ishida,T., Fujii,T., Hata,Y., Murata,M. and Kitamura,K.
Binding mode of CA074, a specific irreversible inhibitor, to bovine cathepsin B as determined by X-ray crystal analysis of the complex
J Biochem (1997) 121, 974-977. PubMed Europe PubMed S I -
Yee,S.T., Okada,Y., Ogasawara,K., Omura,S., Takatsuki,A., Kakiuchi,T., Muno,D., Kominami,E. and Mizuochi,T.
MHC class I presentation of an exogenous polypeptide antigen encoded by the murine AIDS defective virus
Microbiol Immunol (1997) 41, 563-570. PubMed Europe PubMed I -
Feng,M.H., Chan,S.L., Xiang,Y., Huber,C.P. and Lim,C.
The binding mode of an E-64 analog to the active site of cathepsin B
Protein Eng (1996) 9, 977-986. PubMed Europe PubMed I -
Turk,D., Podobnik,M., Popovic,T., Katunuma,N., Bode,W., Huber,R. and Turk,V.
Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: a basis for the design of specific epoxysuccinyl inhibitors
Biochemistry (1995) 34, 4791-4797. PubMed Europe PubMed S I -
Werle,B., Ebert,W., Klein,W. and Spiess,E.
Assessment of cathepsin L activity by use of the inhibitor CA-074 compared to cathepsin B activity in human lung tumor tissue
Biol Chem Hoppe Seyler (1995) 376, 157-164. PubMed Europe PubMed I -
Buttle,D.J., Murata,M., Knight,C.G. and Barrett,A.J.
CA074 methyl ester: a proinhibitor for intracellular cathepsin B
Arch Biochem Biophys (1992) 299, 377-380. PubMed Europe PubMed DOI I -
Yamamoto,A., Kaji,T., Tomoo,K., Ishida,T., Inoue,M., Murata,M. and Kitamura,K.
Crystallization and preliminary X-ray study of the cathepsin B complexed with CA074, a selective inhibitor
J Mol Biol (1992) 227, 942-944. PubMed Europe PubMed DOI S I -
Murata,M., Miyashita,S., Yokoo,C., Tamai,M., Hanada,K., Hatayama,K., Towatari,T., Nikawa,T. and Katunuma,N.
Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro
FEBS Lett (1991) 280, 307-310. PubMed Europe PubMed DOI I -
Towatari,T., Nikawa,T., Murata,M., Yokoo,C., Tamai,M., Hanada,K. and Katunuma,N.
Novel epoxysuccinyl peptides. A selective inhibitor of cathepsin B, in vivo
FEBS Lett (1991) 280, 311-315. PubMed Europe PubMed DOI I
2020
2018
2017
2016
2015
2013
2012
2011
2010
2009
2008
2007
2003
2002
2001
2000
1999
1998
1997
1996
1995
1992
1991
